AVR indicates aortic valve replacement; CABG, coronary artery bypass graft surgery; and IABP, intraaortic balloon pump. Appendix 2. Reviewer Relationships With Industry and Other Entities (Relevant) 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery Peer Reviewer Representation Consultant Speaker s Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Robert Guyton Official Reviewer ACCF/ AHA Task Force on Practice Guidelines None None None Edwards Lifesciences None None Jeffrey Jacobs Official Reviewer ACCF/ AHA Task Force on Data Standards None None None None None None L. Kristin Newby Official Reviewer AHA AstraZeneca None None Eli Lilly* GlaxoSmithKline None None Eric D. Peterson Official Reviewer ACCF/ AHA Task Force on Performance Measures AstraZeneca None None BMS/sanofi-aventis Eli Lilly None None Richard J. Shemin Official Reviewer AHA Edwards Lifesciences None None None None None Hector Ventura Official Reviewer ACCF Board of Governors None Actelion Gilead None None None None Thad F. Waites Official Reviewer ACCF Board of Trustees None None None None None None T. Bruce Ferguson, Jr Organizational Reviewer STS None None None None None None Stephen E. Fremes Organizational Reviewer AATS None None None None Merck Defendant, leaking thoracic aortic Defendant, aortic Colleen G. Koch Organizational Reviewer SCA None None None None None None Harold L. Lazar Organizational Reviewer AATS None None None None None None Walter H. Merrill Organizational Reviewer STS None None None None None None Stanton K. Shernan Organizational Reviewer SCA None Philips Healthcare None None None Plaintiff, communication of echocardiography Joseph S. Alpert Content Reviewer Bayer Sanofi-aventis None None None None None Robert M. Califf Content Reviewer AstraZeneca Daiichi-Sankyo GlaxoSmithKline Medtronic Sanofi-aventis None None Eli Lilly Bayer None None Robbin G. Cohen Content Reviewer None None None None None Defendant, death after minimally invasive heart Defendant, diagnosis of aortic dissection, 2010 Plaintiff, renal failure and Aprotinin, 2010 Mark A. Creager Content Reviewer ACCF/ AHA Task Force on Practice Guidelines AstraZeneca Genzyme Merck Roche Vascutek None None Merck None Plaintiff, Fasudil Development: Asahi Pharma v Actelion, (Continued) Hillis et al 2011 ACCF/AHA CABG Guideline e733 Appendix 2. 